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The transcriptional coactivator peroxisome pro-
liferator-activated receptor-gamma coactivator-1a
(PGC-1a) regulates metabolic genes in skeletal mus-
cle and contributes to the response of muscle to ex-
ercise. Muscle PGC-1a transgenic expression and
exercise both increase the expression of thermo-
genic genes within white adipose. How the PGC-
1a-mediated response to exercise in muscle con-
veys signals to other tissues remains incompletely
defined. We employed a metabolomic approach to
examine metabolites secreted from myocytes with
forced expression of PGC-1a, and identified b-ami-
noisobutyric acid (BAIBA) as a small molecule myo-
kine. BAIBA increases the expression of brown
adipocyte-specific genes in white adipocytes and
b-oxidation in hepatocytes both in vitro and in vivo
through a PPARa-mediated mechanism, induces a
brown adipose-like phenotype in human pluripotent
stem cells, and improves glucose homeostasis in
mice. In humans, plasma BAIBA concentrations are
increased with exercise and inversely associated
with metabolic risk factors. BAIBA may thus96 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc.contribute to exercise-induced protection from
metabolic diseases.
INTRODUCTION
Exercise is an effective intervention for both the prevention and
the treatment of obesity and type 2 diabetes (Knowler et al.,
2002). Recent studies suggest that skeletal muscle integrates
many of the signals contributing to the salutary effects of
exercise (Bassel-Duby and Olson, 2006). The transcriptional
coactivator peroxisome proliferator-activated receptor-gamma
coactivator-1a (PGC-1a) controls an extensive set of metabolic
programs within skeletal muscle and in part regulates the adap-
tive response of muscle to exercise (Handschin and Spiegelman,
2006; Olesen et al., 2010). PGC-1a regulates these metabolic
programs by binding to nuclear receptors and other transcription
factors to form active transcriptional complexes (Puigserver
et al., 1999). Exercise enhances the expression of PGC-1a,
which results in increased mitochondrial biogenesis and fatty
acid b-oxidation, greater glucose transport, and an induction of
muscular fiber type switching toward a more oxidative pheno-
type (Lin et al., 2002; Michael et al., 2001; Wu et al., 1999).
Transgenic mice with muscle-specific PGC-1a expression
show an enhanced ability to perform endurance exercise and
have an increased peak oxygen uptake (Calvo et al., 2008).
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of brown adipocyte-specific genes within white adipose tissue
(WAT) and an increased adipose respiratory phenotype (Bos-
tro¨m et al., 2012), suggesting that skeletal muscle signals to
other tissues to alter their function. In addition, exercise in-
creases mitochondrial number and brown adipocyte-specific
gene expression in white adipose depots and ameliorates
glucose intolerance induced by a high-fat diet (Sutherland
et al., 2009; Xu et al., 2011). Exercise also enhances the brown
proliferative adipocyte progenitor cell population and brown fat
adipogenesis (Xu et al., 2011). Cells expressing brown-adipo-
cyte specific genes have been reported as being interspersed
within the WAT of rodents and humans (so-called beige cells)
(Ishibashi and Seale, 2010; Petrovic et al., 2010) and demon-
strate antidiabetic and antiobesity effects in rodent models
(Kopecky et al., 1995; Melnyk et al., 1997; Seale et al., 2007).
Uncoupling protein-1 (UCP-1) and cell death-inducing DFFA-
like effector a (CIDEA) are among the brown adipocyte-specific
genes increased in expression in WAT by exercise and by mus-
cle-specific PGC-1a expression (Cao et al., 2011). UCP-1 un-
couples the mitochondrial electron transport chain from ATP
synthesis, an activity that is key to the thermogenic role of brown
adipose tissue (BAT) (Enerba¨ck et al., 1997). Likewise, CIDEA is a
mitochondrial brown adipocyte-specific gene with a role in the
regulation of the thermogenic process.
Gene expression arrays and a bioinformatics approach
recently highlighted irisin as a novel secreted protein by which
PGC-1a-dependent signals from muscle drive functional
changes in other tissues (Bostro¨m et al., 2012). There is strong
motivation to investigate whether additional mechanisms trig-
gered by PGC-1a expression in muscle might confer hormone-
like signals to modulate fat metabolism or contribute to the
benefits of exercise, especially with regard to small molecules.
Here we applied a liquid chromatography-mass spectrometry
(LC-MS) metabolic profiling technique to identify small mole-
cules secreted from myocytes with forced expression of PGC-
1a. We then tested the effects of candidate small molecules on
WAT in vitro and in vivo and examined metabolites in the context
of cardiometabolic risk factors and exercise in humans.
RESULTS
b-Aminoisobutyric Acid Is Regulated by PGC-1a and
Increases Expression of Brown Adipocyte-Specific
Genes
Serum-free media taken from muscle cells with forced expres-
sion of PGC1-a increases mRNA levels of several brown adipo-
cyte-specific genes when transferred to primary adipocytes
(Bostro¨m et al., 2012). To identify candidate small molecules
that might be contributing to this phenomenon, we applied
LC-MS metabolic profiling to this media and compared the find-
ings to media from GFP-expressing control cells. As expected,
glucose levels were significantly decreased in the supernatants
of the PGC-1a-overexpressing cells (15.3%, p = 0.025)
(Michael et al., 2001). Four metabolites, b-aminoisobutyric acid
(BAIBA), g-aminobutyric acid (GABA), cytosine, and 20-deoxycy-
tidine, were significantly enriched in the media of the PGC-
1a-overexpressing myocytes (BAIBA, 2.7-fold increase, p =
0.01; GABA, 1.9-fold increase, p = 0.004; cytosine, 3.9-foldCincrease, p = 0.02; 20-deoxycytidine, 3.4-fold increase, p =
0.02) (Figure 1A).
We assessed the ability of these candidate molecules to in-
crease the expression of brown adipocyte-specific genes using
the primary stromal vascular fraction isolated from subcutane-
ous (inguinal) WAT of mice during 6 days of the differentiation
process to mature adipocytes. BAIBA treatment enhanced
UCP-1 and CIDEAmRNA by 5.3-fold and 2.25-fold, respectively,
as assessed by quantitative PCR (Figure 1B). GABA, cytosine,
and 20-deoxycytidine treatment did not induce concordant upre-
gulation of brown adipocyte-specific genes, so we focused sub-
sequent analyses on BAIBA. BAIBA concentrations in the low
micromolar range significantly increased UCP-1 in the primary
adipocytes in a dose-dependent manner (Figure 1C). By
contrast, BAIBA did not significantly alter the expression of the
canonical white adipocyte gene adiponectin (ADIPOQ), which
is also expressed to a similar extent in the beige cell population
(Wu et al., 2012). To strengthen the link between BAIBA secretion
and PGC1-a expression, we analyzed the concentration of
BAIBA in the media of muscle cells in response to increased
expression of PGC1-a using an adenoviral vector. Increased
levels of PGC-1a lead to an increase in the concentration of
BAIBA in the media (Figure S1 available online).
Exposure of Human-Induced Pluripotent Stem Cells to
BAIBA during Differentiation to Mature White
Adipocytes Induces a Brown Adipocyte-like Phenotype
Since BAIBA induced expression of brown adipocyte-specific
genes in primary adipocytes differentiated from the stromal
vascular fraction, we investigated whether BAIBA would induce
a browning response in human pluripotent stem cells during their
differentiation to mature white adipocytes (Figure S2). BJ fibro-
blasts reprogrammed with modified RNA (BJ RiPS) human
induced pluripotent stem cells (IPSCs) were differentiated into
mesenchymal progenitor cells as previously reported (Ahfeldt
et al., 2012). Lentiviral-mediated expression of PPARG2 or
both PPARG2 and CCAAT/enhancer-binding protein b (CEBPB)
in these human pluripotent stem cell-derived mesenchymal pro-
genitor cells was used to program their differentiation into either
white or brown mature adipocytes, respectively (Enerba¨ck et al.,
1997; Kajimura et al., 2009; Wright et al., 2000). Administration of
BAIBA to IPSCs differentiated into mature white adipocytes
conferred a dose-dependent increase in the expression of
brown-adipocyte specific genes, including UCP-1, CIDEA, and
PRDM16. Expression of ELOVL3, a critical enzyme for lipid accu-
mulation and metabolic activity in brown adipocytes, was also
slightly increased (Figure 2A). BAIBA did not significantly alter
the expression of the canonical white adipocyte gene adiponec-
tin (ADIPOQ) (Figure S3A). The effect of BAIBA on the expression
of brown adipocyte-specific genes was reproduced in white
adipocytes derived from other human pluripotent cell lines (Fig-
ure S3B). By contrast, mesenchymal progenitor cells differenti-
ated into mature brown adipocytes in the presence of BAIBA
did not exhibit an increase in the classical browning response
genes, suggesting BAIBA does not initiate the thermogenic
response in BAT in vitro (Figure S3C). One prior publication found
that BAIBA does not affect UCP-1expression in intrascapular
BAT in vivo (Begriche et al., 2008), which might relate to known
differences between the development of beige cells andell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc. 97
GABA
μμ M
GF
P α
PG
C-1
0.0
0.2
0.4
0.6
0.8
μ M
GF
P α
PG
C-1
0
1
2
3
4
5
BAIBA
μ M
GF
P
0
2
4
6
8
2'-deoxycytidineCytosine
μ M
GF
P
0
1
2
3
** ***
**
α
PG
C-1
α
PG
C-1
A
No
rm
ali
ze
d 
m
RN
A
Co
ntr
ol
GA
BA
Cy
tos
ine
2'-
de
ox
yc
yti
din
e
BA
IBA
Co
ntr
ol
GA
BA
Cy
tos
ine
2'-
de
ox
yc
yti
din
e
BA
IBA
Co
ntr
ol
GA
BA
Cy
tos
ine
2'-
de
ox
yc
yti
din
e
BA
IBA
0
2
4
6
8
10
UCP-1
CIDEA ADIPOQ
*
**
B
No
rm
ali
ze
d 
UC
P-
1 
m
RN
A
Co
ntr
ol
M 
BA
IBA
μ
0.3
 M
 BA
IBA
μ1 
M 
BA
IBA
μ3 
M 
BA
IBA
μ5 
0
2
4
6
8
10C
*
*
Figure 1. Metabolites Accumulate in the Media of Myocytes as a
Result of Forced PGC-1a Expression and Stimulate Expression of
Brown Adipocyte-Specific Genes in Adipocytes
(A) Media from myocytes transduced with an adenoviral vector expressing
either PGC-1a (n = 6) or GFP (n = 6) was analyzed using an LC-MS-based
metabolite profiling method.
(B) BAIBA (5 mM) induces expression of brown adipocyte-specific genes in
primary adipocytes. Additional metabolites tested at physiologically relevant
doses included GABA (3 mM), cytosine (1 mM), and 2-deoxycytidine (15 mM).
BAIBA significantly increased the expression of the brown adipocyte-specific
genes UCP-1 and CIDEA. The expression of adiponectin (ADIPOQ) was un-
changed. Cumulative data from a total of five independent observations are
shown.
(C) BAIBA concentrations in the low micromolar range significantly and dose-
dependently increased the expression of the brown adipocyte-specific gene
UCP-1.
*p% 0.05, **p% 0.01, ***p% 0.001. Data are represented asmean ± SEM. See
also Figure S1.
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98 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc.activation of classical brown fat (Frontini and Cinti, 2010; Wu
et al., 2012).
To establish whether the observed transcriptional changes
conferred functional effects, we assessed the uptake of [3H]-
2-deoxy-D-glucose in the PPARG2-programmed cells. We
observed a striking increase in the basal and insulin-stimulated
glucose uptake in the presence of BAIBA (Figure 2B). Further-
more, the basal oxygen consumption rate (OCR) was found to
be higher in the programmed white adipocytes treated with
BAIBA, as assessed by an extracellular flux analyzer. Oligomycin
was then used to inhibit the ATP synthase. The OCR of white ad-
ipocytes treated with BAIBA remained higher than the untreated
white adipocytes, consistent with increased uncoupling. The
addition of the electron transport chain decoupler carbonyl cya-
nide m-chlorophenylhydrazone (CCCP) allowed the measure-
ment of the maximal respiratory capacity. Programmed white
adipocytes treated with BAIBA showed significantly higher res-
piratory capacity compared to the untreated programmed white
adipocytes (Figures 2C and 2D). In addition, bright-field images
and BODIPY fluorescent staining demonstrate that PPARG2-
programmed cells contain the single large, well-defined
lipid droplet characteristic of mature white adipocytes; this
morphology was maintained when the cells were treated with
BAIBA (Figure 2E). Fluorescent immunostaining revealed a
higher degree of UCP-1 staining in the PPARG2 programmed
white adipocytes treated with BAIBA when compared to un-
treated cells. Together, these data indicate that BAIBA activates
a browning gene program and increases themitochondrial activ-
ity of human IPSCs differentiated into white adipocytes.
BAIBA Induces Increased Expression of Brown/Beige
Adipocyte-Specific Genes In Vivo
To examine whether BAIBA could dose-dependently induce the
expression of brown adipocyte-specific genes in WAT in vivo,
mice were treated with 100 mg/kg/day or 170 mg/kg/day of
BAIBA in drinking water for 14 days based on preliminary
dose escalation studies. BAIBA treatment led to a 2.7-fold
(100 mg/kg/day) and 12.2-fold (170 mg/kg/day) increased
plasma concentration of the metabolite by 14 days (100 mg/
kg/day BAIBA; 2 ± 0.03 mM, p = 0.009, 170 mg/kg/day BAIBA;
8.9 ± 0.5 mM, p < 0.0001) (Figure 3A). Expression analysis of
inguinal WAT using qPCR revealed significant increases in
brown adipocyte-specific genes UCP-1 (100 mg/kg/day BAIBA;
8.8-fold increase, p = 0.03, 170 mg/kg/day BAIBA; 12.1-fold
increase, p = 0.02) and CIDEA (100 mg/kg/day BAIBA; 3.4-fold
increase, p = 0.03, 170 mg/kg/day BAIBA; 5.24-fold increase,
p = 0.005), recapitulating the in vitro findings (Figure 3B). Expres-
sion of PGC-1a and cytochrome cwere also increased following
BAIBA treatment (PGC-1a, 100 mg/kg/day BAIBA; 1.3-fold in-
crease, p = 0.09, 170 mg/kg/day BAIBA; 2.6-fold increase, p =
0.02; cytochrome c, 100 mg/kg/day BAIBA; 1.64-fold increase,
p = 0.03, 170 mg/kg/day BAIBA; 5.8-fold increase, p = 0.04).
BAIBA Levels Are Increased in the Plasma of Muscle
PGC-1a-Expressing and Exercising Mice
Since BAIBA was elevated in the media of cultured myocytes by
forced expression of PGC-1a, we testedwhether plasma concen-
trations of this metabolite were increased in mice with muscle-
specific transgenic expression of PGC-1a (MCK-PGC1a) and
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Figure 2. BAIBA Treatment of BJ RiPS Human iPSCs Induces Brown Adipocyte-Specific Gene Expression and Function
(A) BAIBA significantly and dose-dependently increased the expression of brown-adipocyte-specific genes in human IPSC-derived mature adipocytes.
(B) BAIBA increased both basal and insulin-stimulated glucose uptake in human IPSC-derived adipocytes, assessed by [3H]-2-deoxy-D-glucose transport (data
from three independent observations).
(C) The oxygen consumption rate (OCR) of human IPSC-derived white adipocytes with and without BAIBA treatment; untransduced cells differentiated with
adipogenic media (green line), PPARG2-programmed cells (blue line), and PPARG2-programmed cells treated with BAIBA (black line). The OCR was measured
over time with the addition of oligomycin (a), carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (b), and antimycin (g).
(D) BAIBA significantly increased the maximal OCR of PPARG2-transduced adipocytes (data are from n = 10 independent observations).
(E) Images of untransduced cells, PPARG2-programmed white adipocytes, PPARG2-programmed white adipocytes treated with BAIBA, and PPARG2-CEBPB-
programmed brown adipocytes. Shown from left to right: bright-field images illustrating the morphology of the cells; 40,6-diamidino-2-phenylindole (DAPI)
fluorescent nuclear staining (blue), fluorescent staining with the neutral lipid dye BODIPY (green), and fluorescent images of immunostaining with antibodies
against the marker protein UCP-1 (red) (1003magnification). *p% 0.05, **p% 0.01, ***p% 0.001, ****p < 0.0001. Data are represented as mean ± SEM. See also
Figures S2 and S3.
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BAIBA Induces Browning of White Fatwith chronic exercise in wild-type animals. The MCK-PGC1a
transgenic mouse has 10-fold increased expression of PGC-1a
in gastrocnemius (Viscomi et al., 2011; Wu et al., 2011). Plasma
concentrations of BAIBA were significantly increased 11-fold to
6.5 ± 2.5 mM, p = 0.03, as a result of PGC-1a muscle forced
expression in vivo (Figure 3C). By contrast, the absence of PGC-
1a decreases the plasma concentration of BAIBA as compared
to wild-type controls (0.77-fold decrease, p = 0.046) (Figure 3D).
In exercise-trainedwild-typemice subjected to 3weeks of free
wheel running, UCP-1 expression in the subcutaneous inguinal
WAT was significantly increased by 25-fold compared to seden-
tary controls (Bostro¨m et al., 2012). LC-MS analysis of metabo-
lites extracted from the gastrocnemius and quadriceps ofCexercise trained mice demonstrated a 5.2- ± 0.09-fold, p <
0.0001 and 2.2- ± 0.5-fold, p < 0.0001, increase in BAIBA con-
centrations, respectively. Analysis of plasma from the exercise
trainedmice confirmed a highly significant increase in the plasma
concentration of BAIBA (19% increase to 2.6 ± 0.05 mM, p =
0.001) as compared to sedentary controls (Figure 3E).
BAIBA Decreases Weight Gain and Improves Glucose
Tolerance in Mice
Since browning of WAT improves glucose homeostasis and
reduces weight gain (Bostro¨m et al., 2012), we examined the
functional effect of BAIBA on weight gain and glucose tolerance
in vivo. Six-week-old mice were either treated with BAIBAell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc. 99
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Figure 3. BAIBA Induces Expression of
Brown Adipocyte-Specific Genes in WAT
In Vivo, andMuscle-Specific PGC-1a Expres-
sion and Exercise Significantly Increase
Plasma BAIBA Levels
(A) The plasma concentration of BAIBA in mice
given 100mg/kg/day (n = 5) or 170mg/kg/day (n = 5)
of the metabolite in their drinking water significantly
increased over 14 days as compared to age-
matched control mice (n = 5).
(B) Expression of brown adipocyte-specific genes in
inguinal WAT from control mice () (n = 5), mice
treated with 100 mg/kg/day BAIBA for 14 days (+)
(n = 5), or mice treated with 170 mg/kg/day BAIBA
for 14 days (++) (n = 5).
(C) Plasma BAIBA from muscle-specific PGC-1a
transgenic mice (n = 5) was analyzed using LC-MS
and compared to age-matched control mice (n = 5).
(D) Plasma BAIBA from PGC-1a knockout mice (n =
9) was analyzed using LC-MS and compared to
age-matched control mice (n = 8).
(E) Mice were subjected to a 3 week free wheel
running exercise regimen (n = 6) or housed as
sedentary controls (n = 6), and plasma BAIBA levels
were assessed by LC-MS. *p % 0.05, **p % 0.01,
***p % 0.001, ****p < 0.0001. Data are represented
as mean ± SEM.
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BAIBA Induces Browning of White Fat(100 mg/kg/day) or remained untreated (control mice). Their
weights were monitored weekly. Weight was slightly decreased
in the mice by the end of BAIBA treatment (ANOVA, p = 0.01)
(Figure 4A). Analysis of body composition using MRI demon-
strated BAIBA treatment significantly decreased body fat in the
mice (body fat, control = 13.1% ± 1.25%; BAIBA = 9% ±
0.92%, p = 0.02) (Figure 4B). Consistent with the effects on ther-
mogenic and b-oxidation gene expression and body weights,
analysis with metabolic cages indicated that oxygen consump-
tion (VO2) and whole-body energy expenditure were increased
in the BAIBA-treated mice (VO2, two-way ANOVA, p% 0.0001,
energy expenditure, two-way ANOVA, p% 0.0001) (Figures 4C
and 4D) without any significant difference in activity (control =
8,758 ± 417.5 beam breaks per day, BAIBA = 9,504 ± 1,043
beam breaks per day, p = 0.52) (Figure 4E) or food intake (con-
trol = 3.79 ± 0.4 g per day, BAIBA = 4.1 ± 0.2 g per day, p =
0.5) (Figure 4F). The mice were also challenged with an intraper-
itoneal glucose tolerance test (IPGTT) (Figure 4G). BAIBA was
found to significantly improve the glucose tolerance in the mice
as determined by the area under the curve of the IPGTT
(15.9%, p% 0.05) (Figure 4H).
PPARa Mediates BAIBA-Induced Effects on Adipose
Tissue In Vitro and In Vivo
We next examined how BAIBA may be driving the increase in
thermogenic gene expression. In a focused interrogation of po-
tential downstream mediators, we observed that BAIBA signifi-
cantly increases the expression of PPARa in white adipocytes
both in vitro (2.4-fold increase, Figure 5A) and in the inguinal
white fat depot in vivo (2.2-fold increase, Figure 5B). PPARa is
a key transcription factor known to stimulate the expression of
UCP-1 (Bostro¨m et al., 2012; Komatsu et al., 2010). We were
interested to find that the selective PPARa antagonist GW6471
significantly abrogated the BAIBA-stimulated increase in ther-100 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Incmogenic gene expression in primary adipocytes (Figure 5C).
The functional interaction between the BAIBA and GW6471
treatments on thermogenic gene expression was confirmed
using two-way ANOVA (p < 0.005). To further define the contribu-
tion of PPARa to the browning response of primary white adipo-
cytes in vitro, we isolated the stromal vascular fraction from
the subcutaneous WAT of PPARa null mice and differentiated
the cells into mature adipocytes in the presence or absence of
BAIBA. Analysis of the thermogenic gene expression in these
cells using qPCR demonstrated a loss of the BAIBA-induced
browning effect in the setting of PPARa deficiency (Figure 5D),
consistent with the findings seen with the biochemical inhibitor.
The role of PPARa in the BAIBA-induced increase in thermo-
genic gene expression in WAT in vivo was also examined
using PPARa null mice. PPARa null mice were treated with
100 mg/kg/day BAIBA in drinking water for 14 days. qPCR anal-
ysis of subcutaneous (inguinal) WAT demonstrated that BAIBA
failed to increase expression of thermogenic genes, including
UCP-1, CIDEA, PGC-1a, and cytochrome c, in the PPARa null
mice (Figure 5E). Therefore, these results indicate that BAIBA
increases expression of the browning gene program through a
specific PPARa-dependent mechanism.
BAIBA Increases Hepatic b-Oxidation through PPARa
BAIBA may also function to induce additional tissue-specific
salutary effects. Exercise has been shown to increase liver
b-oxidation (Oh et al., 2006; Rabøl et al., 2011; Rector et al.,
2011). Therefore we investigated whether BAIBA would directly
induce b-oxidation gene expression in hepatocytes in vitro.
Hepatocytes were incubated with 5 mMBAIBA for 6 days. BAIBA
significantly increased the expression of PPARa (5.4-fold, p <
0.0001), carnitine palmitoyltransferase 1 (CPT1) (2.2-fold, p <
0.0001), the very-long-chain acyl-CoA dehydrogenase (ACADvl)
(1.3-fold, p = 0.03), the medium-chain acyl-CoA dehydrogenase.
Figure 4. BAIBA Decreases Weight Gain and Improves Glucose Tolerance in Mice
(A) The weights of mice given 100 mg/kg/day BAIBA (n = 8) in their drinking water compared to untreated controls (n = 8).
(B) The percentage body fat of 100 mg/kg/day BAIBA treated mice (n = 8) compared to untreated controls (n = 8).
(C) Diurnal oxygen consumption of control mice (n = 8) and BAIBA (100 mg/kg/day)-treated mice (n = 8).
(D) Diurnal energy expenditure of control mice (n = 8) and BAIBA (100 mg/kg/day)-treated mice (n = 8).
(E) Activity of control mice (n = 8) and mice treated with BAIBA 100 mg/kg/day.
(F) Food consumption of control mice and mice treated with BAIBA 100 mg/kg/day.
(G) Mice treated with BAIBA 100 mg/kg/day for 14 weeks showed significantly improved glucose tolerance as determined by an IPGTT.
(H) The area under the curve of an IPGTT comparing BAIBA-treated mice to untreated controls (control, n = 8; BAIBA, n = 8). *p < 0.05. Data are represented as
mean ± SEM.
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BAIBA Induces Browning of White Fat(ACADm) (1.2-fold, p = 0.005), and acyl-CoA oxidase 1 (ACOX1)
(1.2-fold p = 0.004) (Figure 6A). The interaction between BAIBA
and b-oxidation gene expression was also determined to be
significant by two-way ANOVA (p < 0.0001).
As BAIBA increased the expression of b-oxidation genes
in vitro, we investigated whether BAIBA would induce hepatic
b-oxidation gene expression in vivo. The expression of key
genes involved in fatty acid b-oxidation wasmeasured in the liver
of mice treated with 100 mg/kg/day BAIBA for 14 days using
qPCR. As in vitro, BAIBA significantly increased the expression
of PPARa (1.73-fold p = 0.03), CPT1 (2.5-fold p = 0.0005),
ACADvl (1.3-fold p = 0.04), ACADm (1.2-fold p < 0.05), and
ACOX1 (1.4-fold, p = 0.03) (Figure 6B). The functional interaction
between BAIBA and b-oxidation gene expression was confirmed
using two-way ANOVA (p < 0.0001).CeTo establish whether the observed transcriptional changes
conferred functional effects, we measured the respiratory
rate of hepatocytes treated with BAIBA for 6 days at a range
of concentrations. The addition of the electron transport chain
uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydra-
zone (FCCP) allowed the measurement of the maximal
respiratory capacity. BAIBA treatment significantly and dose
dependently increased the maximal oxygen consumption rate
(OCR) of the hepatocytes (ANOVA, p = 0.03) (Figure 6C).
Together these data demonstrate that BAIBA induces a tran-
scriptional change in hepatocytes leading to a more oxidative
phenotype.
We then examined whether BAIBA is driving the increase in
hepatic fatty acid b-oxidation through a conserved PPARa
mechanism, as was observed with brown-adipocyte genell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc. 101
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Figure 5. PPARa Functions Downstream of BAIBA
(A) BAIBA (5 mM) induces expression of PPARa in primary adipocytes over 6 days (six independent observations).
(B) Expression of PPARa in inguinal WAT from control mice (n = 5) and mice treated with 100 mg/kg/day BAIBA for 14 days (n = 5).
(C) Primary adipocytes treated with BAIBA (5 mM) and/or GW6471 for 6 days. yp < 0.05, yyp < 0.01 compared to BAIBA treatment.
(D) BAIBA (5 mM) failed to induce expression of brown adipocyte-specific genes in primary adipocytes isolated from the inguinal WAT of PPARa null mice (six
independent observations).
(E) Expression of brown adipocyte-specific genes in inguinal WAT from wild-type (WT) control mice (n = 5), WT mice treated with 100 mg/kg/day BAIBA for
14 days (n = 5), PPARa null control mice (n = 5), and PPARa null mice treated with 100 mg/kg/day BAIBA for 14 days (n = 5). *p < 0.05, **p% 0.01 compared to
control. Data are represented as mean ± SEM. See also Figure S4.
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BAIBA Induces Browning of White Fatexpression in white adipocytes. We show that BAIBA signifi-
cantly increases the expression of PPARa both in vitro and
in vivo. PPARa is known to regulate hepatic free fatty acid trans-
port, uptake, and catabolism via b-oxidation (Berger and Moller,
2002; Gulick et al., 1994). The BAIBA-induced increase in
expression of the fatty acid b-oxidation genes, CPT1, ACADvl,
ACADm, and ACOX1 was abolished by the selective PPARa
antagonist, GW6471 (Figure 6D). The functional interaction
between the BAIBA and GW6471 treatments on b-oxidation
gene expression was confirmed using two-way ANOVA (p <
0.0001).
The role of PPARa in the BAIBA-induced increase in hepatic
fatty acid b-oxidation gene expression in in vivo was also exam-
ined using PPARa null mice. PPARa null mice were treated with
100 mg/kg/day BAIBA in drinking water for 14 days. Expression
analysis of liver using qPCR demonstrated that BAIBA failed to
increase expression of b-oxidation genes, including CPT1,
ACADvl, ACADm, and ACOX1, in the PPARa null mice (Fig-
ure 6E). Together, these results indicate that BAIBA increases
hepatic fatty acid oxidation gene expression through a PPARa-
dependent mechanism.102 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier IncBAIBA Plasma Concentrations Are Inversely Correlated
with Cardiometabolic Risk Factors in Humans and Are
Increased during Exercise Training
We examined the association of plasma BAIBA levels with meta-
bolic traits in a large human cohort study. In 2,067 random sub-
jects enrolled in the longitudinal, community-based Framingham
Heart Study (FHS), BAIBA levels were inversely correlated with
fasting glucose (p = 0.0003), insulin (p < 0.0001), the Homeo-
static Model Assessment-Insulin Resistance (HOMA-IR) (p <
0.0001), triglycerides (p < 0.0001), and total cholesterol (p <
0.0001) in age- and sex-adjusted analyses. In addition, there
was a trend toward an inverse association with BMI (p = 0.08).
We also assessed BAIBA concentrations in humans before
and after an exercise training intervention. As part of the
HERITAGE Family Study, sedentary subjects were recruited for
a 20 week program of supervised exercise training as described
in the Experimental Procedures. Metabolomic profiling was per-
formed on plasma from 80 subjects before and after the exercise
training intervention. Following the 20 week exercise program,
the average VO2 max of the subjects had increased by more
than 20%. The plasma BAIBA concentration increased by 17%.
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Figure 6. BAIBA Increases Hepatic b-Oxidation through PPARa
(A) BAIBA (5 mM) induces expression of fatty acid b-oxidation genes in hepatocytes treated for 6 days (control = 6; BAIBA, 5 mM = 6).
(B) BAIBA dose-dependently induces expression of hepatic fatty acid b-oxidation genes in vivo. Expression of fatty acid b-oxidation genes in the liver of control
mice (n = 5) and mice treated with 100 mg/kg/day BAIBA for 14 days (n = 5).
(C) BAIBA dose-dependently increases the maximal oxygen consumption rate of hepatocytes.
(D) qPCR of key b-oxidation genes in hepatocytes treated with BAIBA and/or PPARa antagonist GW6471 for 6 days (data from five independent observations).
yyyp% 0.001, yyyyp < 0.0001 compared to BAIBA treatment.
(E) Expression of b-oxidation genes in liver from PPARa null control mice (n = 5) and PPARa null mice treated with 100 mg/kg/day BAIBA for 14 days (n = 5). *p <
0.05, **p% 0.01, ***p% 0.001, ****p < 0.0001 compared to control. All data are represented as mean ± SEM.
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compared with the murine exercise data.
Integration of Human Genetic and Transcriptional Data
Highlights a Role for PGC-1a in BAIBA Generation
The availability of BAIBA levels and genome-wide genotyping in
1,000 FHS participants allowed us to identify genes responsible
for modulating metabolite levels in humans in an unbiased
manner. These analyses highlighted putative enzymes involved
in BAIBA generation (Table 1). AGXT2 encodes the enzyme
alanine-glyoxylate aminotransferase 2, which catalyzes the
transamination between BAIBA and pyruvate. Strong associa-
tion was noted (p = 1.38E-45) between the top SNP at the locus,
rs37370, and BAIBA concentrations in FHS. AGXT2 has previ-
ously been associated with the urine concentration of BAIBA in
humans (Suhre et al., 2011). Other significant associations
involved ACADS (rs476676, p = 2.63E-05) and ACADSBCe(rs11248396, p = 0.0008), which encode enzymes catalyzing
the reaction forming methacryl-CoA from isobutryl-CoA
upstream of BAIBA. The analyses also highlighted HADHA
(rs10165599, p = 0.0008), which encodes the enzyme hydrox-
yacyl-CoA dehydrogenase responsible for the catalysis of the
reaction forming b-hydroxyisobutyryl-CoA from methacryl-CoA
in the biogenesis of BAIBA. In addition to variants in the biosyn-
thetic pathway, SNPs were also identified in genes for two solute
carriers, SLC6A13 (rs2289957, p = 2.1E-10) and SLC6A6
(rs11128708, p = 3.17E-05), which encode the GABA transporter
GAT2 and the taurine transporter TauT, respectively, which
may also function as BAIBA transporters (Bro¨er, 2008; Liu
et al., 1999).
To then examine potential mechanisms by which PGC-1a
expression might increase levels of BAIBA, we performed tran-
scriptional analysis on PGC-1a-overexpressingmyocytes. There
was striking overlap between BAIBA pathway participantsll Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc. 103
Table 1. Integration of Human Genetic and Transcriptional Data
Highlights a Role for PGC-1a in BAIBA Generation
Gene
Myocyte PGC-1a Expression FHS GWAS
Fold Change p Value p Value
AGXT2 1.4 <0.01 1.38 3 1045
ACADS 2 <0.05 2.63 3 105
HADHA 2.9 <0.05 8.00 3 104
SLC6A6 2.5 <0.05 3.17 3 105
HIBADH 2.5 <0.05 –
HADH 2.5 <0.05 –
HADH2 1.9 <0.05 –
SLC6A13 – – 2.10 3 1010
ACADSB – – 8.00 3 104
Shown are the transcriptional changes in genes associated with the
BAIBA biosynthesis pathway in primary myocytes expressing PGC-1a
as assessed by expression arrays (left panel). Right panel includes genes
in the BAIBA biosynthesis pathway and the significance of their relation-
ship to BAIBA plasma concentrations in the Framingham Heart Study.
See also Figure S5.
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BAIBA Induces Browning of White Fathighlighted by GWAS and those increased by forced PGC-1a
expression. AGXT2 was found to be increased by PGC-1a
overexpression in myocytes (fold change = 1.4, p < 0.01), as
was the expression of ACADS (fold change = 2.0, p < 0.05)
and HADHA (fold change = 2.9, p < 0.05). The expression of
the TauT transporter, SLC6A6, was also increased by PGC-1a
expression (fold change = 2.5, p < 0.05).
In addition, forced PGC-1a expression in muscle in turn
increased expression of DLD, HIBADH, HADH, and HADH2,
genes encoding the enzymes dihydrolipoamide dehydrogense,
3-hydroxyisobutyrate dehydrogenase, L-3-hydroxyacyl-coen-
zyme A dehydrogenase, and hydroxyacyl-coenzyme A dehydro-
genase, type II, respectively (DLD fold change = 2.78, p < 0.05;
HIBADH fold change = 2.5, p < 0.05; HADH fold change = 2.5,
p < 0.05; HADH2 fold change = 1.9, p < 0.05). These enzymes
catalyze the formation of isobutryl-CoA from valine as part of
the branched-chain alpha-keto acid dehydrogenase complex,
and methylmalonate semialdehyde from b-hydroxyisobutyric
acid in the pathway producing BAIBA. Thus, PGC-1a increases
the expression of genes encoding the metabolic enzymes
required for production and transport of BAIBA in myocytes, a
number of which are genetic determinants of BAIBA plasma con-
centrations in humans (Figure S5).
DISCUSSION
Transgenic mice expressing PGC-1a in their skeletal muscle
display an improved capability for exercise (Calvo et al., 2008).
Muscle-specific PGC-1a expression in mice also increases the
expression of brown adipocyte-specific genes and changes
the characteristics ofWAT to amore brown-like phenotype (Bos-
tro¨m et al., 2012). These cells have been termed beige cells (Ish-
ibashi and Seale, 2010; Petrovic et al., 2010). A similar effect has
been identified in the WAT of mice undergoing exercise pro-
grams (Bostro¨m et al., 2012; Sutherland et al., 2009; Xu et al.,
2011). The identification of the PGC-1a-dependent polypeptide
hormone irisin, which is secreted into circulation from muscle104 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Incand triggers the browning response of WAT, establishes one
mechanism by which signals from muscle during exercise can
mediate energy metabolism in other tissues (Bostro¨m et al.,
2012). However, this recent discovery does not exclude a poten-
tial role for other mediators, especially small molecules.
BAIBA was identified in a screen of small molecules generated
by myocytes expressing PGC-1a in vitro and was subsequently
found to be increased in the plasma of both chronically exercised
and muscle-specific PGC-1a transgenic mice. Intramuscular
levels of BAIBA were also strikingly increased by exercise,
though elevation of BAIBA in other tissues is also possible.
BAIBA increases the expression of brown adipocyte-specific
genes both in vitro and in vivo through a PPARa-mediatedmech-
anism. BAIBA also functions to increase hepatic fatty acid
b-oxidation through PPARa. Treating mice with BAIBA improves
glucose tolerance. We were interested to find that BAIBA treat-
ment during differentiation of white adipocytes from BJ RiPS
IPSCs also induces a brown adipocyte-like phenotype with
concordant functional effects on basal and insulin-stimulated
glucose uptake and oxygen consumption. In humans, BAIBA
plasma concentrations are increased by regular exercise and
are significantly inversely correlated with multiple cardiometa-
bolic risk factors. Finally, by integrating human genetic data
and in vitro transcriptional findings, we highlight a cassette of
BAIBA biosynthetic enzymes that are under PGC-1a transcrip-
tional control in muscle. We note that while the browning effect
appears to be operative in our studies, our findings do not
exclude the possibility that macroscopic brown adipose depots
in mice increase energy expenditure and contribute to the
observed effects.
BAIBA is a nonprotein b-amino acid that can be generated by
catabolism of the branched-chain amino acid valine. Our
expression studies would seem to highlight a role for PGC-1a
expression in muscle with the production of BAIBA from valine.
Fasting plasma concentrations of valine are correlated with
obesity and serum insulin (Felig et al., 1969; Newgard et al.,
2009), and we recently identified valine plasma concentration
as a predictor of future development of diabetes (Wang et al.,
2011). Skeletal muscle is a major site of branched-chain amino
acid utilization, and during exercise catabolism of the branched-
chain amino acids is elevated (Harper et al., 1984; Shimomura
et al., 2006). Furthermore, the expression of genes in the valine
degradation pathway was found to be increased in the skeletal
muscle of physically active members of twin pairs compared to
their inactive cotwins (Leskinen et al., 2010). Several enzymes of
the valine degradation pathway are shared with that of b-oxida-
tion of fatty acids (ACADSB, ACADS, ACADM, HADHA, and
HADH), a number of which we found to be transcriptionally
controlled by PGC-1a in myocytes. It would seem evolutionarily
advantageous to integrate the production of a metabolite
myokine signal with the b-oxidation pathway, the primary
source of energy for muscle during endurance exercise. Thus,
our findings suggest a possible connection between valine uti-
lization in skeletal muscle during exercise and beneficial effects
on peripheral WAT.
Independently, BAIBA treatment has been found to reduce
weight gain in partially leptin-deficient (ob/+) mice (Begriche
et al., 2008). Glucose tolerance was improved in the ob/+ mice
treated with BAIBA, consistent with the diminished weight.
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oxidation and reduces de novo lipogenesis in the liver (Begriche
et al., 2008; Maisonneuve et al., 2004; Note et al., 2003). Interest-
ingly, the effect of BAIBA on hepatic lipid metabolismmirrors the
action of exercise, which has also been shown to increase liver
fatty acid oxidation and decrease hepatic lipogenesis through
PPARa (Oh et al., 2006; Rabøl et al., 2011; Rector et al., 2011).
The effects of BAIBA on browning of white adipose depots
were not evaluated in any prior studies. Our studies demonstrate
the PPARa-dependent mechanism of BAIBA’s salutary effects
on liver b-oxidation and extend the prior literature by identifying
its link to PGC-1a, browning of WAT, and relationship to chronic
exercise. Future work may also uncover beneficial effects of
BAIBA on other tissues. Our work also highlights BAIBA as a
potential disease marker in human populations.
While we demonstrate that BAIBA increases expression of
PPARa, and that BAIBA-induced browning of WAT requires
this nuclear receptor, as yet the direct mechanism of action up-
stream of PPARa is unknown. PPARa null mice remain resistant
to cold, can activate cold-induced thermogenesis, and express
equivalent levels of UCP-1 in intrascapular brown adipose tissue
compared to wild-type controls (Kersten et al., 1999). Moreover,
as PPARa null mice do not have reduced UCP-1 expression in
WAT compared to controls following cold exposure (Xue et al.,
2005), absence of PPARa does not blunt the general browning
effect. Therefore, our results indicate that BAIBA increases
browning gene expression through a specific PPARa-dependent
mechanism. BAIBAmay function to activate a cell surface recep-
tor since structurally similar metabolites, including butyrate and
isobutyrate, activate short chain carboxylic acid receptors in
white adipocytes (Brown et al., 2003). Ascertaining the cell
signaling pathways by which BAIBA leads to increased PPARa
expression will be a focus of future studies.
In summary, we identify BAIBA as a small molecule myokine
representing the first in its class of nonadrenergic activators of
the thermogenic program in WAT (Whittle and Vidal-Puig,
2012). The identification of BAIBA as a PGC-1a-mediated and
exercise-triggered signal has significant implications not only
for our understanding of exercise and its protective role against
the development of metabolic diseases, but also for potential
therapeutics for type 2 diabetes and the metabolic syndrome.
EXPERIMENTAL PROCEDURES
Myocyte Culture
Primary satellite cells (myoblasts) were isolated and differentiated into myo-
tubes as previously described (Bostro¨m et al., 2012; Megeney et al., 1996).
At day 2 of differentiation, myocytes were transduced with an adenovirus ex-
pressing either PGC-1a or GFP as previously described (St-Pierre et al., 2003).
At 24 hr posttransduction, cells were washed with PBS and freestyle media
(GIBCO/Invitrogen). Freestyle media was added to GFP and PGC-1a-express-
ing myocytes, and cells were incubated for 24 hr. Media was collected and
cleared with centrifugation (1,000 g, 4C for 5 min 3 3). The supernatant
was then snap frozen in aliquots.
Culture and Differentiation of the Mouse Primary Adipocytes
Isolated from Inguinal White Adipose Stromal Vascular Fraction
Primary white adipose stromal vascular cells were fractionated as previously
described (Soukas et al., 2001). Stromal vascular cells were then cultured
and induced to differentiate into adipocytes according to published methods
(Bostro¨m et al., 2012; Seale et al., 2011). During the 6 day differentiation pro-Cecess, cells were cultured with saline (control); GABA 3 mM; cytosine 1 mM;
20-deoxycytidine 15 mM; and BAIBA 0.3, 1, 3, and 5 mM.
Maintenance of Pluripotent Cells, Generation of Mesenchymal
Progenitor Cells, and Adipocyte Differentiation
Human induced pluripotent stem cells were maintained and differentiated into
mature brown and white adipocytes as previously described (Ahfeldt et al.,
2012; Schinzel et al., 2011). Differentiation was carried out either in the
absence of BAIBA, in the case of controls, and with two concentrations of
BAIBA at 1 mMor 10 mM in the differentiation media. Adipogenic differentiation
medium was supplemented for 16 days with doxycyline 700 ng/ml, and
afterward cells were maintained in culture in the absence of doxycycline until
day 21.
Production of Lentivirus and Transduction
Lentivirus production and transduction of cells with Lenti-PPARG2 or Lenti-
CEBPB were performed as previously described (Ahfeldt et al., 2012).
Glucose Uptake Assay
Glucose uptake was measured by incubating IPSC-derived adipocytes with
2-deoxy-D-[3H] glucose 0.5 mCi/ml (Perkin-Elmer) as described previously
(Ahfeldt et al., 2012).
Measurement of Adipocyte OCR
Cells were plated in gelatin-coated XF24-well cell culture microplates (Sea-
horse Bioscience) and differentiated into adipocytes. Oxygen consumption
andmitochondrial functionweremeasured by XF24 Extracellular Flux Analyzer
(Seahorse Biosciences) as described previously (Ahfeldt et al., 2012).
Hepatocyte Culture
H4IIE hepatocytes (ATCC) were seeded at 200,000 cells per well in a 24-well
collagen I-coated plate. The cells were incubated in MEM media (ATCC sup-
plemented with 10% FBS (Sigma) and penicillin/streptomycin) with 5 mM
BAIBA (n = 6), 1 mM GW6471 PPARa antagonist (n = 6), and 1 mM GW6471
and 5 mM BAIBA (n = 6) for 6 days.
Hepatocyte Respirometry
H4IIE hepatocytes were plated at 40,000 cells per well and grown for 6 days in
Oxoplates OP96F (PreSens) with MEM + 10% FBS media (Sigma Aldrich).
Serum-freeMEMmedia (100 ml) containing BAIBA in a range of concentrations
(0–10 mM) (n = 6 per dose) was added into the wells of an OxoPlate. The media
was exchanged every 2 days with the addition of fresh compounds. After
6 days each well was then overlaid with 250 ml of mineral oil after the addition
of 5 mM of final concentration of carbonyl cyanide 4-(trifluoromethoxy)phenyl-
hydrazone (FCCP). Wells containing oxygen-free water (cal 0) and air-satu-
rated water (cal 100) served as standards. Oxygen-free water was prepared
by dissolving 1 g of sodium sulfite in 100 ml of water. Air-saturated water
was prepared by shaking 100ml of water vigorously for 2min. The oxygen con-
centration in each well was measured immediately and at 15 min and 30 min
after mineral oil addition. Fluorescence of each well was measured in dual
kinetic mode (Multiskan Ascent CF, Thermo Lab- Systems). Filter pair 1
(544/650 nm) detects fluorescence of the indicator dye. The second filter
pair (544/590 nm) measures fluorescence of the reference dye. Oxygen ten-
sion was calculated according to the Stern-Volmer equation and transformed
into nanomoles of oxygen. The difference between baseline, 15 min, and
30 min oxygen tension was used to calculate the oxygen consumption per
min per well.
Animal Experimentation
Muscle-specific PGC-1a transgenic mice were generated and maintained as
previously described (Bostro¨m et al., 2012; Lin et al., 2002). For the exercise
experiments, 12-week-old B6 mice were used (Jackson Laboratory, Bar Har-
bor, ME). Endurance exercise was carried out using free wheel running for
3 weeks (n = 6) (Rasbach et al., 2010). Controls were age matched sedentary
littermates (n = 6). For the short-term BAIBA treatment cohort, 6-week-old
C57BL6/J mice (Jackson Laboratory, Bar Harbor, ME) were weight matched
and assigned to groups for treatment. Mice were treated with either
100 mg/kg/day or 170 mg/kg/day BAIBA in their drinking water for 2 weeksll Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Inc. 105
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BAIBA Induces Browning of White Fatand fed a standard chow diet ad libitum (Prolab RMH 3000-5P75, Labdiet).
129S4/SvJae-Pparatm1Gonz/J mice (Jackson Laboratory) were weight
matched and assigned to groups for treatment. Mice were treated with
100 mg/kg/day BAIBA in their drinking water for 2 weeks and fed a standard
chow diet ad libitum. For the long-term BAIBA treatment cohort, 6-week-old
C57BL6/J mice (Jackson Laboratory, Bar Harbor, ME) were weight matched
and assigned to groups for treatment (n = 11 per group). Mice were treated
with 100 mg/kg/day BAIBA in their drinking water for 14 weeks and fed a stan-
dard chow diet ad libitum (Prolab RMH 3000-5P75, Labdiet).
Study mice were fasted and sacked, and plasma was collected via left ven-
tricular puncture at completion of the study (week 16). Inguinal WAT and liver
were rapidly dissected, snap frozen in liquid nitrogen, and stored at80C un-
til mRNA extraction. All mice were housed in a controlled temperature, lighting,
and humidity environment.
All animal experiments were approved by the Subcommittee on Research
Animal Care at Massachusetts General Hospital.
Indirect Calorimetry
All experiments were performed with 6-week-old mice treated with either
BAIBA (100 mg/kg/day) or water for 14 weeks (n = 8 mice per group). A Pheno-
Master system (TSE Systems, Calo-(D)/Feed/BW-XZ, 16 mice) was used to
monitor oxygen consumption, carbon dioxide production, food intake, daily
body mass, and locomotory activity. The PhenoMaster system was calibrated
before each experiment. Animals were subjected to a 7-day acclimation period
in a training cage without monitoring to habituate to the environment of the
metabolic cages. Animals were maintained in normal cedar bedding at 22C
throughout the monitoring period. Twice hourly measurements for each animal
were obtained for oxygen and carbon dioxide with ad libitum access to food
and water (or water plus BAIBA) on a controlled 12 hr light/dark cycle. Cages
contained one mass sensor to monitor food intake and a second sensor
attached to a glass housing to measure body mass. Oxygen consumption is
expressed normalized to body mass.
Intraperitoneal Glucose Tolerance Test
Mice (n = 11 per group) were fasted for 6 hr with free access to water prior to
the IPGTT, conducted as previously described (Wang et al., 2013).
Gene Expression Analysis
Total RNA from human cell lines, mouse inguinal WAT stromal vascular fraction
derived primary adipocytes, hepatocytes, and mouse WAT and liver was
extracted with Trizol (Invitrogen) and purified via the RNeasy mini kit (QIAGEN)
according to the manufacturer’s instructions. The RNA yield was determined
using the NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies).
RNA was normalized and converted to cDNA using the Superscript
First-Strand Kit (Invitrogen). Quantitative RT-PCR was performed using a
Realplex Mastercycler (Eppendorf) with the Quantifast-SYBR Green PCR
mix (QIAGEN). All data were normalized to 18SrRNA or HPRT and quantitative
measures obtained using the D-D-CT method.
Framingham Heart Study
Analyseswere performed in 2,067 individuals in theOffspring Cohort whowere
free of diabetes and cardiovascular disease and had measurement of BAIBA
concentrations in fasting plasma samples (Wang et al., 2011). Genotyping
was performed on the Affymetrix GeneChip Human Mapping 500K Array
SetR and 50K Human Gene Focused PanelR with parameters and data anal-
ysis as previously described (Rhee et al., 2013). The human study protocols
were approved by the Institutional Review Boards of Boston University Medi-
cal Center and Massachusetts General Hospital, and all participants provided
written informed consent.
HERITAGE Clinical Exercise Study
The HERITAGE Family Study is a clinical trial that enrolled 557 individuals of
various ages (16–65 years) to determine the effects of 20 weeks of highly
controlled endurance training on physiologicmeasures and risk factors for car-
diometabolic disease. Only individuals who were previously sedentary, free of
pre-existing disease, and not taking any medications that would affect any of
the outcome variables were entered into the study (Bouchard et al., 1995).
Endurance training was conducted (3 days/week for a total of 60 exercise ses-106 Cell Metabolism 19, 96–108, January 7, 2014 ª2014 Elsevier Incsions) on cycle ergometers that were computer controlled to maintain the par-
ticipants’ heart rates at fixed percentages of their aerobic capacity (VO2max).
The training program started at 55% of VO2max for 30 min/session and grad-
ually increased to 75%of VO2max for 50min/session, where it wasmaintained
during the last 6 weeks of training. Peripheral plasma samples were collected
from 80 HERITAGE participants before and after the 20 week endurance
training program. Of the participants in this study, 50% were male. The
mean age was 34 years, and the mean BMI was 26. Baseline V02 max was
2,577 ml 02/min, which increased to 3,007 ml 02/min after training.
Metabolic Profiling
Metabolic profiling of amino acids, biogenic amines, and other polar plasma
metabolites were analyzed by LC-MS as previously described (Roberts
et al., 2012; Wang et al., 2011). Metabolite concentrations were determined
using the standard addition method.
Statistical Analyses
For metabolite analyses in FHS, log transformation of BAIBA concentrations
was applied to approximate a normal distribution. Partial correlation coeffi-
cients were estimated between BAIBA and the following metabolic variables,
after adjustment for age and sex: bodymass index (BMI), fasting glucose, fast-
ing insulin, total cholesterol, triglycerides, homeostasis model assessment of
insulin resistance (HOMA-IR), and the homeostasis model assessment of b
cell function (HOMA-B), calculated as previously described (Wang et al., 2011).
For FHS GWAS analyses, a linear mixed effects model that accounts for
familial relatedness with an additive genetic model with one degree of freedom
was used (Chen and Yang, 2010).
For animal studies, all results, unless otherwise stated, are expressed as
means, and error bars depict SEM. A two-tailed Student’s t test or ANOVA
was used to determine p value.
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